These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9200132)

  • 1. Some doubts about the basic concept of hole-board test.
    Bilkei-Gorzó A; Gyertyán I
    Neurobiology (Bp); 1996; 4(4):405-15. PubMed ID: 9200132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The mechanisms of the anxiolytic action of 1-(2-pyrimidinyl)-piperazine derivatives, serotonin agonists].
    Talalaenko AN; Kharin NA
    Eksp Klin Farmakol; 1993; 56(2):11-3. PubMed ID: 8102289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of rat behavior in hole-board: II) multivariate analysis of modifications induced by diazepam.
    Casarrubea M; Sorbera F; Crescimanno G
    Physiol Behav; 2009 Mar; 96(4-5):683-92. PubMed ID: 19385023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of taurine on rat behaviors in three anxiety models.
    Kong WX; Chen SW; Li YL; Zhang YJ; Wang R; Min L; Mi X
    Pharmacol Biochem Behav; 2006 Feb; 83(2):271-6. PubMed ID: 16540157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of angelica essential oil in social interaction and hole-board tests.
    Min L; Chen SW; Li WJ; Wang R; Li YL; Wang WJ; Mi XJ
    Pharmacol Biochem Behav; 2005 Aug; 81(4):838-42. PubMed ID: 16005501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in head-dipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice.
    Takeda H; Tsuji M; Matsumiya T
    Eur J Pharmacol; 1998 May; 350(1):21-9. PubMed ID: 9683010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial.
    Ramos A; Pereira E; Martins GC; Wehrmeister TD; Izídio GS
    Behav Brain Res; 2008 Nov; 193(2):277-88. PubMed ID: 18590774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
    Briones-Aranda A; López-Rubalcava C; Picazo O
    Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine.
    de Jongh R; Groenink L; van Der Gugten J; Olivier B
    Psychopharmacology (Berl); 2002 Jan; 159(2):176-80. PubMed ID: 11862346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the acute effects of amitriptyline and fluoxetine on anxiety using grooming analysis algorithm in rats.
    Enginar N; Hatipoğlu I; Firtina M
    Pharmacol Biochem Behav; 2008 May; 89(3):450-5. PubMed ID: 18304624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microstructure of rat behavioral response to anxiety in hole-board.
    Casarrubea M; Sorbera F; Santangelo A; Crescimanno G
    Neurosci Lett; 2010 Sep; 481(2):82-7. PubMed ID: 20600602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aversive learning as a mechanism for lack of repeated anxiolytic-like effect in the elevated plus-maze.
    Stern CA; Carobrez AP; Bertoglio LJ
    Pharmacol Biochem Behav; 2008 Oct; 90(4):545-50. PubMed ID: 18533241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(6):489-542. PubMed ID: 18615308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparisons between anxiety tests for selection of anxious and non anxious mice.
    do-Rego JC; Viana AF; Le Maître E; Deniel A; Rates SM; Leroux-Nicollet I; Costentin J
    Behav Brain Res; 2006 May; 169(2):282-8. PubMed ID: 16497395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evaluation of the stress-induced social avoidance model of anxiety.
    Leveleki C; Sziray N; Levay G; Barsvári B; Soproni K; Mikics E; Haller J
    Brain Res Bull; 2006 Mar; 69(2):153-60. PubMed ID: 16533664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
    Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study with two types of elevated plus-maze (transparent vs. opaque walls) on the anxiolytic effects of midazolam, one-trial tolerance and fear-induced analgesia.
    Albrechet-Souza L; Oliveira AR; De Luca MC; Tomazini FM; Santos NR; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):571-9. PubMed ID: 15866360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rats with constitutionally upregulated/downregulated platelet 5HT transporter: differences in anxiety-related behavior.
    Hranilovic D; Cicin-Sain L; Bordukalo-Niksic T; Jernej B
    Behav Brain Res; 2005 Dec; 165(2):271-7. PubMed ID: 16139900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
    Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
    J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.